Bandingkan Harga & Kinerja GTS Internasional Tbk. (GTSI) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan GTS Internasional Tbk. dan Organon Pharma Indonesia Tbk.: GTS Internasional Tbk. diperdagangkan di Rp165 (kapitalisasi pasar 2,64 T, volume 24 jam 20,64 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: GTS Internasional Tbk. jauh lebih besar — sekitar 25,3× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| GTSI | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 2,64 T | 104,4 M |
Volume | 20,64 jt | — |
Lot | 206,42 rb | — |
Perputaran | 3,34 M | — |
Harga Rata-rata | 161,78 | — |
Nilai Transaksi | 3,34 M | — |
Harga Ekuilibrium Indikatif | 165 | — |
Volume Ekuilibrium Indikatif | 4,9 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang GTS Internasional Tbk.
PT GTS Internasional Tbk (the “Company”) was established based on Notarial Deed No. 32 dated June 29, 2012 of Martina, S.H. The Company started its commercial operations in August 2019. The Company’s parent entity is PT Hateka Trans Internasional and ultimate parent entity is PT Humpuss Intermoda Transportasi Tbk.
Selengkapnya di halaman GTSI →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
